Evidence map›Paper›PMID 39585691›Full record

SynthesisJAMA network open2024

Outcomes in Randomized Clinical Trials Testing Changes in Daily Water Intake: A Systematic Review.

Nizar Hakam, Jose Luis Guzman Fuentes, Behnam Nabavizadeh, Architha Sudhakar, Kevin D Li, Catherine Nicholas, Jason Lui, Peggy Tahir, Charles P Jones, Stephen Bent and 1 more

Abstract readSystematic Review
In one paragraph

Synthesis in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nizar HakamDepartment of Urology, University of California, San Francisco.
Jose Luis Guzman FuentesDepartment of Urology, University of California, San Francisco.
Behnam NabavizadehDepartment of Urology, Weill Cornell Medicine, New York, New York.
Architha SudhakarDepartment of Urology, University of California, San Francisco.
Kevin D LiDepartment of Urology, University of California, San Francisco.
Catherine NicholasDepartment of Urology, University of California, San Francisco.
Jason LuiDepartment of Urology, University of California, San Francisco.
Peggy TahirUCSF Library, University of California, San Francisco.
Charles P JonesDepartment of Urology, University of California, San Francisco.
Stephen BentDepartment of Medicine, University of California, San Francisco.
Benjamin N BreyerDepartment of Urology, University of California, San Francisco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Several public recommendations exist regarding the amount of daily water intake, yet the supporting evidence is not clear, and benefits of increasing water consumption are not well-established. Objective: To summarize evidence from randomized clinical trials (RCTs) pertaining to the health-related outcomes associated with increased or decreased daily water consumption. Evidence Review: A systematic search of PubMed, Web of Science, and Embase was performed up to April 6, 2023. Studies were included if they aimed to assess the impact of daily water consumption by any defined amount on any health-related outcome. Findings: Of 1464 records screened, 18 (1%) eligible studies were included in the review. Among eligible studies, 15 (83%) were parallel group RCTs, and 3 (16%) were crossover studies. Interventions in these studies consisted of a recommendation to alter the daily amount of water intake by a specific amount for a predefined period ranging between 4 days and 5 years, while the control groups were mostly asked to maintain their usual intake habits. The studies assessed various populations. Recurring primary end points included weight loss, fasting blood glucose level, headache, urinary tract infection, and nephrolithiasis. Consuming additional water was associated with greater weight loss (range, 44%-100% more than control conditions) and fewer nephrolithiasis events (15 fewer events per 100 participants over 5 years). Single studies suggested benefits related to migraine prevention, urinary tract infection, diabetes control, and hypotension. Ten studies (55%) reported at least 1 positive result, and 8 studies (44%) reported negative results. Conclusions and Relevance: This systematic review found that there is a limited number of clinical trials in the literature assessing the benefits of increasing water intake related to a large variety of health outcomes. While the quality and quantity of evidence is limited, a small number of studies suggested benefits of water intake on weight loss and nephrolithiasis, while single studies raised the possibility of benefits for patients with migraine, urinary tract infection, diabetes, and hypotension. Given the low cost and low adverse-effect profile of water, further well-designed studies should assess benefits in these specific conditions.

Indexed as

DrinkingRandomized Controlled Trials as TopicAdultBlood GlucoseFemaleHumansMaleMiddle AgedUrinary Tract InfectionsWeight LossBlood Glucose

Identifiers

PMID39585691
PMCPMC11589796

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.